Condiciones de salud que propóleo de abeja puede ayudar a apoyar.
Bee propolis has been used in traditional medicine for skin wounds, abscesses, and infections since antiquity. Scientific evidence supports its antimicrobial, anti-inflammatory, and wound-healing properties through flavonoid-rich composition. A case report documented use of a honey-propolis-myrrh combination to heal a deep infected abscess wound.
Bee propolis contains CAPE (caffeic acid phenethyl ester) and flavonoids with potent NF-κB inhibitory and antioxidant effects in vascular endothelium. RCTs show propolis supplementation reduces LDL-C by 10–15%, reduces oxidized LDL, and decreases arterial inflammation (hsCRP, IL-6). It inhibits platelet aggregation and reduces endothelial adhesion molecule expression.
Bee propolis contains CAPE and flavonoids that inhibit NF-κB and reduce pro-inflammatory cytokines relevant to autoimmune inflammation. Clinical and animal studies support anti-inflammatory and immunomodulatory activity in RA and IBD. CAPE promotes Treg cells and suppresses Th17 responses.
Bee propolis has documented antimicrobial, anti-inflammatory, and wound-healing properties relevant to insect bites and stings, particularly for preventing secondary infection and reducing inflammation. It is a constituent of traditional apitherapy for skin injuries and a PubMed-indexed study confirmed synergistic wound-healing effects of propolis and honey. It appears in homeopathic and natural products for bite and sting symptom relief.
Bee propolis has demonstrated clinical superiority over acyclovir for HSV-induced blister (cold sore) healing in multiple trials. A 2021 systematic review and meta-analysis found propolis statistically superior to acyclovir for healing HSV skin lesions (p=0.0001). It is antibacterial, antifungal, antiviral, and wound-healing through its flavonoid and caffeate content.
Bee propolis has documented in vitro antifungal activity against Candida albicans and other Candida species confirmed across multiple geographic sources. It inhibits germ tube formation and hyphal growth—key Candida virulence factors. Multiple peer-reviewed studies and integrative Candida protocols support its use for Candida and yeast balance.
Bee propolis, a resinous substance produced by bees with anti-inflammatory, antioxidant, and immunomodulatory properties, has been evaluated in a 2024 systematic review and meta-analysis (PubMed PMID 38248221) specifically for recurrent aphthous stomatitis. Multiple RCTs included in this review found propolis reduced healing time, pain, and recurrence of aphthous ulcers. A randomized clinical trial also directly compared propolis versus silver nitrate and other treatments for canker sores, showing significant efficacy.
Bee propolis has been evaluated in multiple RCTs for herpes labialis and shown to be at least equivalent, and in several trials superior, to topical acyclovir 5% cream in reducing healing time and symptom scores. A 2026 meta-analysis confirmed propolis and honey showed better healing outcomes than acyclovir. The most studied formulation is propolis special extract GH 2002 at 0.5% concentration.
Bee propolis has been evaluated in atopic dermatitis studies, including as part of propolis-tea tree oil-aloe vera cream (PTAC) formulations. Its polyphenols and artepillin C inhibit NF-κB and inflammatory mediators. Traditional use for skin inflammation is ancient and cross-cultural.
Bee propolis has demonstrated antifungal activity against Candida species, Trichophyton, and Aspergillus in multiple peer-reviewed in vitro studies and has been evaluated in at least one bench-to-clinic study for onychomycosis. It inhibits phospholipase activity, disrupting fungal adhesion, and shows broad activity against dermatophytes responsible for tinea infections. Its active antifungal components include flavonoids, phenolic acids, and terpenoid esters.
Propolis (bee glue) has demonstrated anti-H. pylori activity in vitro and in clinical studies. It contains flavonoids and phenolic acids with direct antibacterial and anti-inflammatory effects on the gastric mucosa. A 2014 World Journal of Gastroenterology review identified propolis as a clinically-researched natural remedy for H. pylori gastritis.
Propolis extracts have been evaluated in multiple RCTs for periodontal and gingival conditions. A 2021 multicenter RCT in 104 patients with gingivitis and periodontitis found propolis mouthwash significantly reduced modified gingival index at 4 and 8 weeks, and lowered crevicular IL-6. A comprehensive systematic review identified propolis and quercetin as the natural products with the highest antioxidant, anti-inflammatory, and antimicrobial activity in periodontal disease management.
Bee propolis has documented in vitro antiparasitic activity against Giardia lamblia, Toxoplasma gondii, and Leishmania, and is listed among proposed natural treatments for intestinal parasites in EBSCO's complementary medicine resource.
Propolis is a resinous beehive product with broad-spectrum antimicrobial and antiviral properties reviewed across 158 publications for respiratory tract diseases. A clinical study in COVID-19 pneumonia patients showed green Brazilian propolis produced earlier viral clearance and reduced mortality versus standard care. Propolis inhibits SARS-CoV-2 via multiple mechanisms and is active against secondary bacterial lung infection pathogens.
Bee propolis contains antimicrobial flavonoids and caffeic acid phenethyl ester (CAPE) with documented clinical efficacy in reducing respiratory illness duration and severity. An RCT in COVID-19 patients (PROPOLCOVID) showed significantly shorter hospital stays with propolis versus standard care, supporting its use in post-illness recovery.
Bee propolis has documented wound-healing and anti-scar properties supported by clinical studies. Its flavonoids (including caffeic acid phenethyl ester) exhibit anti-inflammatory, antimicrobial, and collagen-modulating effects relevant to scar healing.
Bee propolis has the same evidence as propolis above—in vitro antibiofilm activity against chronic rhinosinusitis pathogens confirmed in a 2023 PMC study, traditional use for respiratory infections, and inclusion in combination sinusitis support products. Antimicrobial and anti-inflammatory mechanisms are established.
Bee propolis is identical in evidence to Propolis—see above. Direct RCT evidence (Esposito et al., 2020, n=122) confirms standardized propolis oral spray reduces sore throat, dysphonia, and throat swelling versus placebo in mild upper respiratory tract infections. Anti-inflammatory and antimicrobial polyphenols are the active mechanism.
Propolis has direct clinical evidence in tonsillopharyngitis. A 2004 RCT (n=328 children) with an echinacea-propolis-vitamin C supplement showed >50% reduction in tonsillopharyngitis incidence. An open-label RCT (n=130 children) with a honey-propolis-Pelargonium-zinc supplement showed significantly lower tonsillitis severity scores vs standard care alone. Propolis exhibits potent antibacterial activity against Streptococcus pyogenes.
Propolis is a bee-derived resin with flavonoids that inhibit COX and LOX enzymes, reducing pulpal inflammation. A 2024 PMC narrative review of 104 studies (53 human clinical trials) confirmed propolis's antimicrobial activity against oral pathogens, anti-inflammatory effects, and utility in endodontic procedures. A 2025 PMC systematic review of 21 dental pain studies ranked propolis among the strongest phytotherapeutic analgesics for dental applications.
Bee propolis exhibits broad-spectrum antiviral and immunomodulatory activity through its flavonoid and phenolic constituents. In vitro and in vivo studies confirm activity against influenza, coronaviruses, rhinovirus, parainfluenza, and HSV. It modulates pro-inflammatory cytokines and activates both innate and adaptive immune responses against viral pathogens.
Oral propolis achieved 75% cure in plane warts and 73% in common warts in a randomized 3-month trial of 135 patients, significantly outperforming both echinacea and placebo. Propolis is rich in flavonoids with antiviral and immunomodulatory properties. Topical propolis formulations also demonstrated wart-clearing activity in an uncontrolled case series of 53 patients.
Bee propolis is a resinous hive product with well-documented antibacterial, anti-inflammatory, and wound-healing properties supported by multiple in vitro, in vivo, and some clinical studies. It shortens healing time, reduces scar formation, and promotes epithelialization and wound contraction.
Bee propolis has traditional use and preclinical/clinical evidence for upper respiratory infections. Its polyphenolic constituents (CAPE, galangin, quercetin) demonstrate antimicrobial, antiviral, and anti-inflammatory activity against respiratory pathogens. A 2023 clinical study found it recommended as supportive therapy for chronic URTI including rhinosinusitis.